LAG3 and neoplasm: In tumor regions where PD-1 is either blocked or PD-1 receptors are absent, Galectin-3 (encoded by LGALS3), produced by both tumor cells and macrophages, can interact with LAG3 on T cell surfaces to suppress IFN-γ secretion and induce T cell apoptosis [21].